TERTiNT, which targets telomerase reverse transcriptase-positive cancers, and WTiNT, which targets Wilms tumor protein-positive cancers, are both in phase 1 in patients with late-stage solid tumors.

Wilms tumor, a common pediatric kidney cancer, is treatable with surgery, chemotherapy, and radiation therapy for optimal ...